Skip to main content
Year archive

CStone Pharmaceuticals — 2020 filings

All 260 regulatory filings released by CStone Pharmaceuticals (2616) in 2020, sourced directly from the official regulator.

260 Filings
2020 Period
2020 filings (260)
Filing Released Lang
INSIDE INFORMATION-DEBT FINANCING TRANSACTION OF AN OVERSEAS SUBSIDIARY RECONSOLIDATION OF WATAGAN
Capital/Financing Update
2020-12-16 English
CLOSING COMPLETION OF MAJOR AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE TARGET EQUITY INTERESTS AND TARGET ASSETS
M&A Activity
2020-12-15 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED U.S. FDA HAS APPROVED GAVRETO (PRALSETINIB) FOR THE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC RET-MUTANT AND RET FU
Regulatory Filings
2020-12-10 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTION PASSED AT THE 2020 SECOND EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements
2020-12-09 English
CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings
2020-12-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-12-09 English
Provision of Financial Guarantee to the Company's Controlled Subsidiaries and Invested Companies
Regulatory Filings
2020-12-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-12-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-12-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-12-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2020
Regulatory Filings
2020-12-03 English
Monthly Returns
Share Issue/Capital Change
2020-12-01 English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO ESOP AND GRANT OF RSU PURSUANT TO THE POST-IPO RSU SCHEME
Regulatory Filings
2020-11-30 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2020-11-30 English
APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTORS
Board/Management Information
2020-11-30 English
VOLUNTARY ANNOUNCEMENT-UPDATE ON PROPOSED PLANNING OF SIGNIFICANT EVENT BY CONTROLLING SHAREHOLDER
Regulatory Filings
2020-11-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-11-27 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE RESULTS OF GEMSTONE-302 SUGEMALIMAB HAS THE POTENTIAL TO PROVIDE A NEW TREATMENT OPTION FOR PATIENTS WITH ADVANCED NSCLC
Regulatory Filings
2020-11-23 English
VOLUNTARY ANNOUNCEMENT - GLOBAL STRATEGIC PARTNERSHIP BETWEEN CSTONE AND EQRX TAKES EFFECT FOLLOWING EARLY TERMINATION OF HSR WAITING PERIOD
Capital/Financing Update
2020-11-20 English
CONTINUING CONNECTED TRANSACTION IN RELATION TO COAL SALES TRANSACTIONS
Regulatory Filings
2020-11-19 English
Notification Letter
Report Publication Announcement
2020-11-16 English
Circular
Proxy Solicitation & Information Statement
2020-11-16 English
Circular
Regulatory Filings
2020-11-16 English
FORM OF PROXY FOR USE AT THE 2020 SECOND EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-11-16 English
NOTICE OF SECOND EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-11-16 English
VOLUNTARY ANNOUNCEMENT - CHINA'S NMPA HAS ACCEPTED NDA FOR ANTI-PD-L1 MONOCLONAL ANTIBODY SUGEMALIMAB (CS1001) IN FIRST-LINE ADVANCED NSCLC
Regulatory Filings
2020-11-12 English
Voluntary Announcement - CSTONE SUCCESSFULLY SUBMITTED A NDA FOR IVOSIDENIB IN SINGAPORE FOR IDH1-MUTATED R/R AML
Regulatory Filings
2020-11-10 English
NOTICE OF LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED-YANCOAL INTERNATIONAL RESOURCES DEVELOPMENT CO., LIMITED-US$500,000,000 3.50% Senior Guaranteed Bonds due 2023
Capital/Financing Update
2020-11-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2020
Regulatory Filings
2020-11-03 English
Monthly Returns
Share Issue/Capital Change
2020-11-02 English
ANNOUNCEMENT ON RECEIVING THE LETTER OF PERFORMANCE COMMITMENT FROM THE CONTROLLING SHAREHOLDER
Regulatory Filings
2020-10-30 English
VOLUNTARY ANNOUNCEMENT - LICENSE AGREEMENT FOR ANTIBODY DRUG CONJUGATE LCB71 WITH LEGOCHEM BIOSCIENCES, INC.
Capital/Financing Update
2020-10-28 English
DISCLOSEABLE TRANSACTION-CAPITAL INCREASE IN INNER MONGOLIA MINING
Capital/Financing Update
2020-10-28 English
ARTICLES OF ASSOCIATION OF YANZHOU COAL MINING COMPANY LIMITED
Governance Information
2020-10-28 English
INSIDE INFORMATION ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT FOR SUGEMALIMAB (PD-L1) AND CS1003 (PD-1) WITH EQRX, INC.
Capital/Financing Update
2020-10-27 English
CLARIFICATION ANNOUNCEMENT IN RELATION TO MEDIA REPORT
Regulatory Filings
2020-10-23 English
ANNOUNCEMENT ON RECEIVING THE LETTER OF PERFORMANCE COMMITMENT FROM THE CONTROLLING SHAREHOLDER
Regulatory Filings
2020-10-23 English
RESULTS REPORT FOR THE THIRD QUARTER OF 2020
Interim / Quarterly Report Q3 2020
2020-10-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-10-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-10-23 English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE DEEMED DISPOSAL OF 40.8% EQUITY INTERESTS IN HAINAN INTELLIGENT LOGISTICS
Capital/Financing Update
2020-10-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-10-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-10-23 English
VOLUNTARY ANNOUNCEMENT - U.S. FDA GRANTED BREAKTHROUGH THERAPY DESIGNATION TO ANTI-PD-L1 ANTIBODY SUGEMALIMAB FOR THE TREATMENT OF ADULT PATIENTS WITH R/R ENKTL
Regulatory Filings
2020-10-23 English
ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA OF THE THIRD QUARTER OF 2020
Regulatory Filings
2020-10-19 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE THIRD QUARTER OF 2020 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Capital/Financing Update
2020-10-19 English
VOLUNTARY ANNOUNCEMENT - U.S. FDA GRANTED ORPHAN DRUG DESIGNATION TO ANTI-PD-L1 ANTIBODY SUGEMALIMAB FOR THE TREATMENT OF T-CELL LYMPHOMA
Regulatory Filings
2020-10-19 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-10-12 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-10-12 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-10-12 English
COMPLETION OF ISSUE OF SUBSCRIPTION SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2020-10-12 English
Monthly Returns
Capital/Financing Update
2020-10-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2020
Regulatory Filings
2020-10-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-09-30 English
MAJOR AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE TARGET EQUITY INTERESTS AND TARGET ASSETS
M&A Activity
2020-09-30 English
ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE FIFTH MEETING OF THE EIGHTH SESSION OF THE BOARD OF DIRECTORS
Board/Management Information
2020-09-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-09-30 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTION PASSED AT THE 2020 FIRST EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements
2020-09-30 English
INSIDE INFORMATION - ISSUE OF SUBSCRIPTION SHARES UNDER GENERAL MANDATE AND STRATEGIC COLLABORATION WITH PFIZER INVESTMENT
Capital/Financing Update
2020-09-30 English
ANNOUNCEMENT ON THE PARTICIPATION IN 2020 ONLINE COLLECTIVE RECEPTION ACTIVITY FOR INVESTORS
Regulatory Filings
2020-09-25 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES RESULTS FROM TWO STUDIES OF ANTI-PD-1 MONOCLONAL ANTIBODY CS1003 AT THE 2020 ESMO ANNUAL MEETING
Regulatory Filings
2020-09-25 English
INTERIM REPORT 2020
Interim / Quarterly Report H1 2020
2020-09-24 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES PRELIMINARY RESULTS FROM A BRIDGING STUDY OF AVAPRITINIB IN CHINESE PATIENTS WITH UNRESECTABLE OR METASTATIC GASTROINTESTINAL STROMAL TUMORSAT THE 2020 CSCO A
Regulatory Filings
2020-09-24 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES UPDATED RESULTS FROM TWO STUDIES OF ITS ANTI-PD-L1 MONOCLONAL ANTIBODY SUGEMALIMAB (CS1001) AT 2020 CSCO ANNUAL MEETING
Regulatory Filings
2020-09-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-09-22 English
Notification Letter
Report Publication Announcement
2020-09-15 English
Circular
Proxy Solicitation & Information Statement
2020-09-15 English
Proxy Forms
Proxy Solicitation & Information Statement
2020-09-14 English
NOTICE OF 2020 FIRST EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-09-14 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Board/Management Information
2020-09-14 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-09-14 English
VOLUNTARY ANNOUNCEMENT - NMPA HAS ACCEPTED ITS NEW DRUG APPLICATION WITH PRIORITY REVIEW DESIGNATION FOR PRALSETINIB FOR THE TREATMENT OF PATIENTS WITH RET FUSION-POSITIVE NSCLC
Regulatory Filings
2020-09-07 English
Rules of Procedures for Shareholders General Meeting of Yanzhou Coal Mining Company Limited
Governance Information
2020-09-04 English
ARTICLES OF ASSOCIATION OF YANZHOU COAL MINING COMPANY LIMITED
Governance Information
2020-09-04 English
NOTIFICATION LETTER
Report Publication Announcement
2020-09-04 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-09-04 English
PROPOSED PARTICIPATION IN THE CAPITAL INCREASE OF INNER MONGOLIA MINING (GROUP) COMPANY LIMITED THROUGH TENDER PROCESS
Capital/Financing Update
2020-09-04 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-09-03 English
RESIGNATION OF VICE CHAIRMAN OF THE BOARD
Board/Management Information
2020-09-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2020
Share Issue/Capital Change
2020-09-03 English
Monthly Returns
Capital/Financing Update
2020-09-02 English
VOLUNTARY ANNOUNCEMENT - CSTONE RECEIVES US FDA IND CLEARANCE FOR CS1001-201 STUDY TO EVALUATE ANTI-PD-L1 MONOCLONAL ANTIBODY SUGEMALIMAB MONOTHERAPY IN R/R ENKTL
Regulatory Filings
2020-08-31 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-08-28 English
Yanzhou Coal Mining Company Limited Interim Report 2020
Interim / Quarterly Report H1 2020
2020-08-28 English
ANNOUNCEMENT ON INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020
Interim / Quarterly Report H1 2020
2020-08-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-08-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-08-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-08-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-08-28 English
OVERSEAS REGULATORY ANNOUNCEMENT-NOTICE OF 2020 INTERIM RESULTS PRESENTATIONS
Investor Presentation
2020-08-26 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-08-25 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-08-20 English
PUBLICATION OF THE 2020 INTERIM RESULTS OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Report Publication Announcement
2020-08-19 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2020
Interim / Quarterly Report H1 2020
2020-08-18 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-08-14 English
VOLUNTARY ANNOUNCEMENT-UPDATE ON PROPOSED PLANNING OF SIGNIFICANT EVENT BY CONTROLLING SHAREHOLDER
Capital/Financing Update
2020-08-14 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2020 THIRD TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update
2020-08-13 English
INSIDE INFORMATION - BUSINESS UPDATES
Capital/Financing Update
2020-08-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2020
Share Issue/Capital Change
2020-08-05 English
DATE OF BOARD MEETING
Report Publication Announcement
2020-08-05 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES RECEIVED POSITIVE CHMP OPINION FOR AVAPRITINIB FOR THE TREATMENT OF ADULTS WITH UNRESECTABLE OR METASTATIC PDGFRA D842V MUTANT GASTRO
Regulatory Filings
2020-08-05 English
Monthly Returns
Regulatory Filings
2020-08-03 English
ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA OF THE SECOND QUARTER OF 2020
Regulatory Filings
2020-07-30 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2019
Environmental & Social Information
2020-07-24 English
VOLUNTARY ANNOUNCEMENT - U.S. ORPHAN DRUG DESIGNATION FOR THE ANTI-PD1 ANTIBODY CS1003
Regulatory Filings
2020-07-24 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED SUBMISSION OF NEW DRUG APPLICATION TO U.S. FDA FOR PRALSETINIB FOR THE TREATMENT OF ADVANCED RET MUTANT AND RET FUSION-POSI
Regulatory Filings
2020-07-20 English
VOLUNTARY ANNOUNCEMENT - GRANT OF RESTRICTED SHARE UNITS AND PROPOSED ISSUE OF SHARES PURSUANT TO THE POST-IPO RSU SCHEME
Capital/Financing Update
2020-07-16 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE SECOND QUARTER OF 2020 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Regulatory Filings
2020-07-16 English
GRANT OF SHARE OPTIONS
Capital/Financing Update
2020-07-13 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-07-13 English
VOLUNTARY ANNOUNCEMENT-PROPOSED PLANNING OF SIGNIFICANT EVENT BY CONTROLLING SHAREHOLDER
Regulatory Filings
2020-07-12 English
VOLUNTARY ANNOUNCEMENT - REGISTRATIONAL STUDY OF PRALSETINIB IN CHINESE RET-FUSION NSCLC PATIENTS ACHIEVED THE EXPECTED RESULTS, CSTONE PLANS TO SUBMIT AN NDA TO THE NMPA FOR PRALSETINIB IN THE NEAR F
Regulatory Filings
2020-07-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2020
Regulatory Filings
2020-07-06 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED PUBLICATION IN THE LANCET ONCOLOGY SHOWING DURABLE CLINICAL BENEFITS OF AVAPRITINIB IN NAVIGATOR TRIAL PATIENTS WITH PDGFRA
Regulatory Filings
2020-07-06 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2020 SECOND TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update
2020-07-03 English
Monthly Returns
Share Issue/Capital Change
2020-07-02 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-06-30 English
Next Day Disclosure Return
Transaction in Own Shares
2020-06-28 English
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Transaction in Own Shares
2020-06-24 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 23, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-23 English
VOLUNTARY ANNOUNCEMENT - CSTONE RELEASED PRECLINICAL DATA ON ITS FOUR PIPELINE PRODUCTS
Regulatory Filings
2020-06-23 English
SECOND ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings
2020-06-22 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2020 FIRST CLASS MEETING OF THE HOLDERS OF A SHARES AND THE RESOLUTIONS PASSED AT THE 2020 FIRST CLASS MEETING OF THE HOLDERS OF H SHARES
Declaration of Voting Results & Voting Rights Announcements
2020-06-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-06-19 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2019 ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements
2020-06-19 English
The Detailed Working Rules for the Sustainable Development Committee of the Board of Directors of Yanzhou Coal Mining Company Limited
Governance Information
2020-06-19 English
The Detailed Working Rules for the Strategy and Development Committee of the Board of Directors of Yanzhou Coal Mining Company Limited
Governance Information
2020-06-19 English
The Detailed Working Rules for the Remuneration Committee of the Board of Directors of Yanzhou Coal Mining Company Limited
Remuneration Information
2020-06-19 English
The Detailed Working Rules for the Nomination Committee of the Board of Directors of Yanzhou Coal Mining Company Limited
Governance Information
2020-06-19 English
The Detailed Working Rules for the Audit Committee of the Board of Directors of Yanzhou Coal Mining Company Limited
Governance Information
2020-06-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-06-19 English
ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE FIRST MEETING OF THE EIGHTH SESSION OF THE BOARD OF DIRECTORS
Board/Management Information
2020-06-19 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-06-19 English
ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings
2020-06-19 English
CHANGE OF EMPLOYEE REPRESENTATIVE DIRECTOR AND EMPLOYEE REPRESENTATIVE SUPERVISOR
Board/Management Information
2020-06-19 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-06-18 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES PRESENTED UPDATED PART 1 DATA FROM PIONEER TRIAL OF AVAPRITINIB SHOWING ROBUST REDUCTIONS IN CUTANEOUS DISEASE SYMPTOMS IN PATIENTS W
Regulatory Filings
2020-06-17 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-06-17 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-06-16 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-06-12 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-06-11 English
ANNOUNCEMENT-PARTICIPATION IN THE LAWSUITSAS A THIRD PARTY
Legal Proceedings Report
2020-06-11 English
VOLUNTARY ANNOUNCEMENT ON INCREASE OF SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER AND ITS CONCERT PARTIES
Major Shareholding Notification
2020-06-11 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-06-05 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-06-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2020
Share Issue/Capital Change
2020-06-04 English
Monthly Returns
Share Issue/Capital Change
2020-06-02 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-29 English
VOLUNTARY ANNOUNCEMENT-SHARE REPURCHASE
Transaction in Own Shares
2020-05-29 English
Notification Letter
Report Publication Announcement
2020-05-29 English
Circular
AGM Information
2020-05-29 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-29 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-28 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-05-27 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE PHASE IB DATA AND PROGRESS WITH THE PIVOTAL TRIAL OF CS1001 IN NON-SMALL CELL LUNG CANCER
Regulatory Filings
2020-05-26 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-05-22 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-05-22 English
FORM OF PROXY FOR ANNUAL GENERAL MEETING
AGM Information
2020-05-21 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-05-21 English
PROPOSED GRANT OF SHARE OPTIONS, CONNECTED TRANSACTION, PROPOSALS FOR SPECIFIC MANDATE TO ISSUE SHARES TO A CONNECTED PERSON, PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION
AGM Information
2020-05-21 English
(1) PROPOSED ISSUE OF NEW SHARES UNDER THE POST-IPO RSU SCHEME PURSUANT TO SPECIFIC MANDATE&#x3b; (2) CONNECTED TRANSACTION INVOLVING ISSUE OF NEW SHARES TO A CONNECTED PERSON UNDER THE POST-IPO RSU S
Capital/Financing Update
2020-05-21 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-21 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-21 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-20 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-19 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-18 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-15 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-15 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-05-15 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-14 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-14 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-13 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-05-13 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-12 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-12 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-11 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2020
Share Issue/Capital Change
2020-05-07 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-06 English
Monthly Returns
Regulatory Filings
2020-05-06 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-05-05 English
Next Day Disclosure Return
Transaction in Own Shares
2020-05-04 English
VOLUNTARY ANNOUNCEMENT-SHARE REPURCHASE
Transaction in Own Shares
2020-05-04 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-04-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-04-29 English
NOTIFICATION LETTER
Report Publication Announcement
2020-04-29 English
REPLY SLIP FOR THE 2020 FIRST CLASS MEETING OF THE HOLDERS OF H SHARES
Regulatory Filings
2020-04-29 English
Form of Proxy for Use at the 2020 FIRST Class Meeting of the Holders of H Shares
Proxy Solicitation & Information Statement
2020-04-29 English
NOTICE OF 2020 FIRST CLASS MEETING OF THE HOLDERS OF H SHARES
Proxy Solicitation & Information Statement
2020-04-29 English
REPLY SLIP FOR THE 2019 ANNUAL GENERAL MEETING
AGM Information
2020-04-29 English
Form of Proxy for Use at the Annual General Meeting
AGM Information
2020-04-29 English
NOTICE OF 2019 ANNUAL GENERAL MEETING
AGM Information
2020-04-29 English
2019 ANNUAL REPORT
Annual Report FY 2019
2020-04-28 English
RESULTS REPORT FOR THE FIRST QUARTER OF 2020
Interim / Quarterly Report Q1 2020
2020-04-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-04-28 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES ACCEPTANCE OF ITS FIRST NEW DRUG APPLICATION IN MAINLAND CHINA BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE FIRST-IN-CLASS PRECISION THERAPY AVAPRI
Regulatory Filings
2020-04-23 English
Annual Report 2019
Annual Report FY 2019
2020-04-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-04-22 English
ANNOUNCEMENT ON THE UNAUDITED OPERATIONAL DATA OF COAL BUSINESS OF THE FIRST QUARTER OF 2020
Regulatory Filings
2020-04-22 English
CHANGE OF GENERAL MANAGER
Board/Management Information
2020-04-22 English
SUPPLEMENTAL ANNOUNCEMENT-UPDATE ON THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Annual Report FY 2019
2020-04-22 English
Social Responsibility Report 2019 Of Yanzhou Coal Mining Company Limited
Environmental & Social Information
2020-04-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-04-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-04-22 English
Provision of Financial Guarantee to the Company's Subsidiaries and Granting of Authorization to Yancoal Australia and Its Subsidiaries to Provide Guarantee for the Daily Operation of the Subsidia
Capital/Financing Update
2020-04-22 English
ANNOUNCEMENTIN RELATION TO THE PROVISION FOR IMPAIRMENT FOR ASSETS
Regulatory Filings
2020-04-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-04-22 English
ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE THIRTY-THIRD MEETING OF THE SEVENTH SESSION OF THE BOARD OF DIRECTORS
Board/Management Information
2020-04-22 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE FIRST QUARTER OF 2020 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Regulatory Filings
2020-04-20 English
YANCOAL INTERNATIONAL RESOURCES DEVELOPMENT CO., LIMITED-US$500,000,000 Senior Guaranteed Perpetual Capital Securities Notice on Completion of Redemption
Delisting Announcement
2020-04-15 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-04-14 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-04-08 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-04-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2020
Share Issue/Capital Change
2020-04-06 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED TOP-LINE DATA FROM PHASE I/II ARROW TRIAL IN RET-ALTERED THYROID CANCERS AND COMPLETION OF ROLLING NDA SUBMISSION TO U
Capital/Financing Update
2020-04-02 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2020-04-01 English
Monthly Returns
Share Issue/Capital Change
2020-04-01 English
VOLUNTARY ANNOUNCEMENT-COMPLETION OF THE ACQUISITION OF 10% INTERESTS IN THE MOOLARBEN COAL JOINT VENTURE
Capital/Financing Update
2020-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE PERIOD AS AT 31 DECEMBER 2019
Interim / Quarterly Report FY 2019
2020-03-27 English
CONNECTED TRANSACTION IN RELATION TO THE PROPOSED ACQUISITION OF 10% INTEREST IN THE MOOLARBEN COAL JOINT VENTURE
Capital/Financing Update
2020-03-27 English
PROPOSED CHANGE OF DIRECTORS AND SUPERVISORS
Board/Management Information
2020-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-03-27 English
CONNECTED TRANSACTION-DISPOSAL OF 100% EQUITY INTERESTS OF TRADING COMPANIES
Capital/Financing Update
2020-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-03-27 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RULES OF PROCEDURES FOR SHAREHOLDERS' GENERAL MEETING
Governance Information
2020-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-03-27 English
VOLUNTARY ANNOUNCEMENT - CSTONE SUBMITS NEW DRUG APPLICATION FOR THE TARGETED THERAPY AVAPRITINIB IN TAIWAN FOR THE TREATMENT OF ADULTS WITH ADVANCED PDGFRA EXON 18 MUTANT GASTROINTESTINAL STROMAL TUM
Regulatory Filings
2020-03-27 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2019
Annual Report FY 2019
2020-03-26 English
OVERSEAS REGULATORY ANNOUNCEMENT-NOTICE OF 2019 ANNUAL RESULTS PRESENTATIONS
Investor Presentation
2020-03-25 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED PART 1 RESULTS FROM PRIONEER TRIAL SHOWING BROAD ACTIVITY OF AVAPRITINIB ACROSS MEASURES OF MAST CELL BURDEN, CLINICAL OUTC
Regulatory Filings
2020-03-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-03-17 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-03-16 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-03-12 English
DATE OF BOARD MEETING
Report Publication Announcement
2020-03-12 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-03-10 English
YANCOAL INTERNATIONAL RESOURCES DEVELOPMENT CO., LIMITED US$500,000,000 Senior Guaranteed Perpetual Capital Securities Redemption Notice
Delisting Announcement
2020-03-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2020
Share Issue/Capital Change
2020-03-05 English
Monthly Returns
Capital/Financing Update
2020-03-03 English
PUBLICATION OF THE 2019 ANNUAL RESULTS OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Report Publication Announcement
2020-02-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-02-21 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-02-07 English
VOLUNTARY ANNOUNCEMENT-THE LEASE AGREEMENT
Regulatory Filings
2020-02-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-02-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2020
Share Issue/Capital Change
2020-02-05 English
Monthly Returns
Regulatory Filings
2020-02-03 English
VOLUNTARY ANNOUNCEMENT - AMENDMENT TO THE RESTRICTED SHARE AWARD SCHEME AND GRANT OF RESTRICTED SHARE UNITS PURSUANT TO THE RESTRICTED SHARE AWARD SCHEME
Capital/Financing Update
2020-01-31 English
VOLUNTARY ANNOUNCEMENT - CSTONE SUCCESSFULLY HOSTED THE FIRST U.S. R&D DAY IN NEW YORK
Regulatory Filings
2020-01-24 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT DOSED IN THE GLOBAL PROOF-OF-CONCEPT STUDY OF CS1001 IN COMBINATION WITH BAYER'S REGORAFENIB
Regulatory Filings
2020-01-23 English
ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA OF THE FOURTH QUARTER OF 2019
Regulatory Filings
2020-01-22 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE FOURTH QUARTER OF 2019 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Report Publication Announcement
2020-01-16 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED AYVAKIT (AVAPRITINIB) APPROVED BY THE US FDA FOR THE TREATMENT OF ADULTS WITH UNRESECTABLE OR METASTATIC PDGFRA EXON 18 MUT
Regulatory Filings
2020-01-15 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2020-01-10 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2020 FIRST TRANCHE OF SUPER-SHORT-TERM BONDS AND SUPPLEMENTAL ANNOUNCEMENT ON THE CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 100% EQUITY INT
Capital/Financing Update
2020-01-09 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT DOSED IN THE PHASE III TRIAL OF CS1001 IN COMBINATIONATION WITH CHEMOTHERAPY IN FIRST-LINE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Regulatory Filings
2020-01-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019
Share Issue/Capital Change
2020-01-07 English
VOLUNTARY ANNOUNCEMENT - CSTONE AND BLUEPRINT MEDICINES INITIATE PHASE 1B/2 CLINICAL TRIAL OF FISOGATINIB IN COMBINATION WITH CS1001 FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
Regulatory Filings
2020-01-06 English
Monthly Returns
Regulatory Filings
2020-01-03 English